Masayuki Amano

2.0k total citations
72 papers, 1.5k citations indexed

About

Masayuki Amano is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Masayuki Amano has authored 72 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 42 papers in Virology and 27 papers in Epidemiology. Recurrent topics in Masayuki Amano's work include HIV/AIDS drug development and treatment (47 papers), HIV Research and Treatment (42 papers) and Pneumocystis jirovecii pneumonia detection and treatment (16 papers). Masayuki Amano is often cited by papers focused on HIV/AIDS drug development and treatment (47 papers), HIV Research and Treatment (42 papers) and Pneumocystis jirovecii pneumonia detection and treatment (16 papers). Masayuki Amano collaborates with scholars based in Japan, United States and Hungary. Masayuki Amano's co-authors include Hiroaki Mitsuya, Arun K. Ghosh, Yasuhiro Koh, Debananda Das, Irene T. Weber, Taro Shimizu, Manabu Aoki, Johnson Agniswamy, Yuan-Fang Wang and Abigail Baldridge and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Masayuki Amano

68 papers receiving 1.5k citations

Peers

Countries citing papers authored by Masayuki Amano

Since Specialization

Citations

This map shows the geographic impact of Masayuki Amano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Amano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Amano more than expected).

Fields of papers citing papers by Masayuki Amano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Amano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Amano. The network helps show where Masayuki Amano may publish in the future.

Co-authorship network of co-authors of Masayuki Amano

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Amano. A scholar is included among the top collaborators of Masayuki Amano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Amano. Masayuki Amano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potent HIV‑1 protease inhibitors containing oxabicyclo octanol-derived P2-ligands: Design, synthesis, and X‑ray structural studies of inhibitor-HIV-1 protease complexes 2025 ·Bioorganic & Medicinal Chemistry Letters ·Arun K. Ghosh, (unknown), Monika Yadav, (unknown), Megan Johnson, (unknown), (unknown), (unknown), Masayuki Amano, Oksana Gerlits, Andrey Kovalevsky, Hiroaki Mitsuya	0
2	A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples 2025 ·Scientific Reports ·(unknown), Jeeeun Kim, Yasuhiro Irino, Masayuki Amano, K. Tsuchiya, Kenji Maeda, Mari Terada, Noriko Iwamoto, Shinya Shimada, Hiroaki Mitsuya, Masatoshi Yanagida, Yuki Takamatsu	0
3	An Autopsy Case of <i>Streptococcus dysgalactiae</i> subsp. <i>equisimilis</i> Infectious Endocarditis Accompanied by Streptococcal Toxic Shock Syndrome 2024 ·Internal Medicine ·(unknown), (unknown), (unknown), (unknown), Masayuki Amano, (unknown), (unknown), (unknown), (unknown), Aiko Okazaki, (unknown), (unknown), (unknown)	0
4	Exploration of imatinib and nilotinib-derived templates as the P2-Ligand for HIV-1 protease inhibitors: Design, synthesis, protein X-ray structural studies, and biological evaluation 2023 ·European Journal of Medicinal Chemistry ·Arun K. Ghosh, (unknown), (unknown), (unknown), (unknown), (unknown), Megan Johnson, Yuan-Fang Wang, (unknown), Johnson Agniswamy, Masayuki Amano, Yuki Takamatsu, Shin-ichiro Hattori, Irene T. Weber, Hiroaki Mitsuya	4
5	Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2′ amide-derivatives: Synthesis, biological evaluation and structural studies 2023 ·Bioorganic & Medicinal Chemistry Letters ·Arun K. Ghosh, (unknown), Dana Shahabi, (unknown), (unknown), (unknown), Megan Johnson, Yuan-Fang Wang, Johnson Agniswamy, Masayuki Amano, Irene T. Weber, Hiroaki Mitsuya	3
6	Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron 2023 ·Scientific Reports ·Masayuki Amano, (unknown), Yukari Uemura, Yasuko Ichikawa, (unknown), Nobuyo Higashi‐Kuwata, Shuzo Matsushita, Shinya Shimada, Hiroaki Mitsuya	6
7	Design, Synthesis and X‐Ray Structural Studies of Potent HIV‐1 Protease Inhibitors Containing C‐4 Substituted Tricyclic Hexahydro‐Furofuran Derivatives as P2 Ligands 2022 ·ChemMedChem ·Arun K. Ghosh, (unknown), (unknown), Dana Shahabi, (unknown), (unknown), (unknown), Monika Yadav, Megan Johnson, Johnson Agniswamy, Yuan‐Fang Wang, Shin-ichiro Hattori, (unknown), Manabu Aoki, Masayuki Amano, Irene T. Weber, Hiroaki Mitsuya	5
8	Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants 2022 ·Scientific Reports ·Masayuki Amano, (unknown), Kenji Maeda, Yukari Uemura, Yosuke Shimizu, (unknown), Masao Matsuoka, Shinya Shimada, Hiroaki Mitsuya	5
9	Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence 2021 ·Proceedings of the National Academy of Sciences ·Guangyong Ma, Jun‐ichirou Yasunaga, Kazuya Shimura, Keiko Takemoto, Miho Watanabe, Masayuki Amano, Hirotomo Nakata, (unknown), (unknown), Masao Matsuoka	35
10	Case of endobronchial metastasis from breast cancer accompanied with Cunninghamella bertholletiae tracheobronchial mycetoma 2019 ·Journal of Infection and Chemotherapy ·Kenji Uno, (unknown), Masayuki Matsuda, (unknown), Masayuki Amano, (unknown), (unknown), Takeshi Kawaguchi, Ryuichi Nakano, Hisakazu Yano, Kei Kasahara, Keiichi Mikasa	3
11	Amino-acid inserts of HIV-1 capsid (CA) induce CA degradation and abrogate viral infectivity: Insights for the dynamics and mechanisms of HIV-1 CA decomposition 2019 ·Scientific Reports ·Masayuki Amano, Haydar Bulut, Sadahiro Tamiya, Tomofumi Nakamura, Yasuhiro Koh, Hiroaki Mitsuya	4
12	Synthesis and evaluation of the anti-hepatitis B virus activity of 4′-Azido-thymidine analogs and 4′-Azido-2′-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent 2019 ·Nucleosides Nucleotides & Nucleic Acids ·(unknown), (unknown), (unknown), Hiroki Kumamoto, Manabu Aoki, Masayuki Amano, Satoru Kohgo, Debananda Das, Kazuhiro Haraguchi, Hiroaki Mitsuya, Shuhei Imoto	1
13	Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex 2017 ·Bioorganic & Medicinal Chemistry ·Arun K. Ghosh, Margherita Brindisi, Prasanth R. Nyalapatla, Jun Takayama, (unknown), (unknown), Johnson Agniswamy, Yuan-Fang Wang, Manabu Aoki, Masayuki Amano, Irene T. Weber, Hiroaki Mitsuya	14
14	GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro 2017 ·Scientific Reports ·Masayuki Amano, (unknown), Ravikiran S. Yedidi, (unknown), Hirotomo Nakata, Kalapala Venkateswara Rao, Arun K. Ghosh, Hiroaki Mitsuya	15
15	Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands 2015 ·Bioorganic & Medicinal Chemistry Letters ·Arun K. Ghosh, Jun Takayama, (unknown), (unknown), (unknown), Johnson Agniswamy, Yuan-Fang Wang, Manabu Aoki, Masayuki Amano, Irene T. Weber, Hiroaki Mitsuya	32
16	Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cells 2015 ·Biochemical and Biophysical Research Communications ·Shinya Endo, Masayuki Amano, Nao Nishimura, (unknown), Shikiko Ueno, (unknown), Shiho Fujiwara, Naoko Wada, Shinya Hirata, Hiroyuki Hata, Hiroaki Mitsuya, Yutaka Okuno	12
17	Design of gem‐Difluoro‐bis‐Tetrahydrofuran as P2 Ligand for HIV‐1 Protease Inhibitors to Improve Brain Penetration: Synthesis, X‐ray Studies, and Biological Evaluation 2014 ·ChemMedChem ·Arun K. Ghosh, (unknown), Akira Mizuno, (unknown), Johnson Agniswamy, Yuan‐Fang Wang, Manabu Aoki, (unknown), Masayuki Amano, Irene T. Weber, Hiroaki Mitsuya	20
18	Probing Multidrug‐Resistance and Protein–Ligand Interactions with Oxatricyclic Designed Ligands in HIV‐1 Protease Inhibitors 2010 ·ChemMedChem ·Arun K. Ghosh, Chunxiao Xu, Kalapala Venkateswara Rao, Abigail Baldridge, Johnson Agniswamy, Yuan‐Fang Wang, Irene T. Weber, Manabu Aoki, (unknown), Masayuki Amano, Hiroaki Mitsuya	44
19	Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands 2009 ·Bioorganic & Medicinal Chemistry Letters ·Arun K. Ghosh, Sandra Gemma, Elena Simoni, Abigail Baldridge, D. Eric Walters, (unknown), Yasushi Tojo, Yasuhiro Koh, Masayuki Amano, Hiroaki Mitsuya	11
20	Potent Inhibition of HIV-1 Replication by Novel Non-peptidyl Small Molecule Inhibitors of Protease Dimerization 2007 ·Journal of Biological Chemistry ·Yasuhiro Koh, Shintaro Matsumi, Debananda Das, Masayuki Amano, David A. Davis, Jianfeng Li, (unknown), Abigail Baldridge, Tatsuo Shioda, Robert Yarchoan, Arun K. Ghosh, Hiroaki Mitsuya	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact